Advertisement
After adoption of the Affordable Care Act

Incidence of Early-Stage Breast CA, CRC Up With ACA Adoption

0
No change in incidence of locally advanced or metastatic-stage cancer after ACA adoption
Treatment at a high-volume facility is a significant predictor of improved overall survival in nasopharyngeal cancer

Facility Volume Found to Impact Nasopharyngeal CA Survival

0
Treatment at high-volume facility independently predicts higher overall survival in multivariate model
Higher fiber intake after a diagnosis of nonmetastatic colorectal cancer (CRC) is associated with lower CRC-specific and overall mortality

Fiber Tied to Lower Mortality in Those With Colorectal Cancer

0
Increasing fiber consumption after diagnosis may lower risk of all-cause, CRC-specific mortality
Pricing interventions seem to improve access to healthy food and beverage options with increases in stocking and sales of these items

Pricing Interventions Increase Sales, Intake of Healthy Foods

0
Also linked to reduced purchasing and consumption of unhealthy foods and beverages
About one-quarter of skin biopsies are diagnosed as melanocytic proliferation

Almost One in Four Skin Biopsies Is Melanocytic Proliferation

0
83.1 percent classified as nevi, other benign proliferations such as mildly dysplastic lesions
Not all prescription drug users report receiving warnings about driving impairment

Driving Impairment Warnings Often Not Given With Rx Meds

0
For most drug categories, those who do receive warnings perceive higher risk of impaired driving

Liposuction Can Reduce Lymphedema-Related Swelling

0
Case report describes beneficial effect for three patients with lymphedema affecting the leg or arm
PARP inhibitors demonstrate activity in triple-negative breast cancer tumors without BRCA1/2 mutations

PARP Inhibitors Promising Beyond BRCA1/2 Altered Tumors

0
Talazoparib caused regression in 5 patient-derived xenografts, 4 without germline BRCA1/2 mutations

October 2017 Briefing – Hematology & Oncology

0
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2017. This roundup includes...
Lenalidomide produces hematologic responses in myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis

Response to Lenalidomide Often Suboptimal in MDS/MPN-RS-T

0
Hematological responses seen in three patients with MDS/MPN-RS-T, but the responses not durable